Publications by authors named "Matthew Koller"

The effect that aerobic (AT) and/or strength training (ST) has on altering peak aerobic power (VO2peak), muscle strength, left ventricular (LV) morphology, and diastolic filling in healthy older women is not known. We assessed the effects of 12 weeks of AT, ST, combined aerobic and strength training (COMT), or no training (NT) on VO2peak, muscle strength, LV morphology, and diastolic filling in 31 healthy women (68 +/- 4 years). Relative VO2peak was significantly greater after 12 weeks of AT, ST, or COMT.

View Article and Find Full Text PDF

This study examined the effect of 12 weeks of combined aerobic and resistance training on aerobic capacity, left ventricular ejection fraction, and arterial afterload during submaximal cycle exercise in 18 recent (<1 month from transplantation) cardiac transplant recipients. The main finding of this study is that 12 weeks of combined aerobic and resistance training is an effective intervention to increase aerobic capacity in this population. However, exercise training was not associated with favorable improvements in left ventricular systolic function, because stroke volume and ejection fraction were reduced after training because of an increase in arterial afterload.

View Article and Find Full Text PDF

Background: Type 2 diabetes mellitus (DM-2) is one of the most prevalent chronic diseases of the aged and contributes to a significant amount of cardiovascular disease morbidity and mortality. Exercise training may be beneficial in attenuating the cardiovascular maladaptations associated with DM-2. The purpose of this study was to examine the effects of exercise training on left ventricular (LV) and vascular function in a sample of postmenopausal women with DM-2.

View Article and Find Full Text PDF

The effect of opioid analgesia on tests of muscular function in chronic low back pain (CLBP) is unknown. Twenty-eight subjects with CLBP of at least moderate intensity performed the Sorensen isokinetic exercise test once after receiving 1 microg/kg fentanyl intravenously and once after placebo in a randomized-order double-blind crossover design. Naloxone 3 microg/kg was administered after the fentanyl phase.

View Article and Find Full Text PDF